Please Wait.....
Report
Astaxanthin Market? By Source (Natural, Synthetic) , By Form (Dry, Liquid) By Application (Dietary supplements, Cosmetics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
Astaxanthin Market
The astaxanthin marketwas valued at $0.8 billion in 2023 and is projected to reach $1.6 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.
Astaxanthin is a red-colored pigment that belongs to the category of xanthophyll carotenoid and is present in several microorganisms and marine organisms. Astaxanthin is known for its antioxidant properties and aids in the protection of cells from free radicals. The compound is consumed in the form of supplements to enhance the health of brain, eyes, & skin; regulate high cholesterol levels; and support the immune system. Moreover, astaxanthin is used in the aquaculture industry to integrate pigmentation into farmed trout, salmons, and shrimps. This process elevates theappearance of aquaculture products and enhances their market value.
Increase in awareness regarding fit lifestyle and importance of health supplements is a significant driver of the astaxanthin market. In addition, astaxanthin is a natural product due to which it witnesses a high demand from the supplements and cosmetics industries, owing to surge in inclination toward organic or natural products. In the coming future, the trend of utilizing astaxanthin in crop production is anticipated to acquire notable traction. As per an article published by SpringerLink, a scientific portfolio, application of astaxanthin into rice seedlings eliminates their oxidative stress, regulates their homeostatic balance, and boosts their tolerance toward salinity.
However, the potentialrisk of side effects, such as disturbances in digestive system, due to high dosage of astaxanthin deters several individuals from its consumption and hampers the growth of the market. Furthermore, the extraction of astaxanthin from natural resources is gradually resulting in the depletion of microalgae and other marine organisms. This factor discourages the use of astaxanthin in diverse applications. Contrarily, to address the challenge of resource depletion, several microalgae-producing enterprises have been established across the globe to shift the production of astaxanthin into laboratories. As of September 2022, the European Commission identified 87 enterprises in 17 countries of Europe. These enterprises cultivate the astaxanthin-producing microalgae using photobioreactors. The extraction of astaxanthin from these cultured microalgae offers several benefits such as decreased environmental pollution, availability of scalability opportunities, and reduced exploitation of natural resources.
Segment Review
The astaxanthin market is divided into source, form, application, and region. On the basis of source, the market is bifurcated into natural and synthetic. As per form, it is divided into dry and liquid. Depending on application, it is classified into dietary supplements, cosmetics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of source, the natural segment dominated the market in 2023.
As per form, the dry segment acquired a high stake in the market in 2023.
Depending on application, the dietary supplements segment is projected to account for a high share of the market by 2033.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The key players operating in theglobal astaxanthin marketinclude INNOBIO Limited, Divis Laboratories Limited, Algaecan Biotech, ALGA Technologies, Cyanotech Corporation., Otsuka Pharmaceutical Co., Cardax, Fenchem, BGG, and Fuji Chemical Industries Company Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Patient/epidemiology data at country, region, global level
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Source
- Natural
- Synthetic
By Form
- Dry
- Liquid
By Application
- Dietary supplements
- Cosmetics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- INNOBIO Limited
- Divis Laboratories Limited
- Algaecan Biotech
- ALGA Technologies
- Cyanotech Corporation.
- Otsuka Pharmaceutical Co.
- Cardax
- Fenchem
- BGG
- Fuji Chemical Industries Company Limited
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ATORVASTATIN CALCIUM MARKET, BY FORM
4.1. Market Overview
4.1.1 Market Size and Forecast, By Form
4.2. Tablets
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Others
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ATORVASTATIN CALCIUM MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Hypercholesterolemia
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Hyperlipidemia
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ATORVASTATIN CALCIUM MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Overview
6.1.1 Market Size and Forecast, By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Drug Store Retail Pharmacies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Online Providers.
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ATORVASTATIN CALCIUM MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Form
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By Distribution Channel
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Atorvastatin Calcium Market
7.2.6.1. Market Size and Forecast, By Form
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By Distribution Channel
7.2.7. Canada Atorvastatin Calcium Market
7.2.7.1. Market Size and Forecast, By Form
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By Distribution Channel
7.2.8. Mexico Atorvastatin Calcium Market
7.2.8.1. Market Size and Forecast, By Form
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By Distribution Channel
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Form
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By Distribution Channel
7.3.5. Market Size and Forecast, By Country
7.3.6. France Atorvastatin Calcium Market
7.3.6.1. Market Size and Forecast, By Form
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By Distribution Channel
7.3.7. Germany Atorvastatin Calcium Market
7.3.7.1. Market Size and Forecast, By Form
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By Distribution Channel
7.3.8. Italy Atorvastatin Calcium Market
7.3.8.1. Market Size and Forecast, By Form
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By Distribution Channel
7.3.9. Spain Atorvastatin Calcium Market
7.3.9.1. Market Size and Forecast, By Form
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By Distribution Channel
7.3.10. UK Atorvastatin Calcium Market
7.3.10.1. Market Size and Forecast, By Form
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By Distribution Channel
7.3.11. Rest of Europe Atorvastatin Calcium Market
7.3.11.1. Market Size and Forecast, By Form
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By Distribution Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Form
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By Distribution Channel
7.4.5. Market Size and Forecast, By Country
7.4.6. China Atorvastatin Calcium Market
7.4.6.1. Market Size and Forecast, By Form
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By Distribution Channel
7.4.7. Japan Atorvastatin Calcium Market
7.4.7.1. Market Size and Forecast, By Form
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By Distribution Channel
7.4.8. India Atorvastatin Calcium Market
7.4.8.1. Market Size and Forecast, By Form
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By Distribution Channel
7.4.9. South Korea Atorvastatin Calcium Market
7.4.9.1. Market Size and Forecast, By Form
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By Distribution Channel
7.4.10. Australia Atorvastatin Calcium Market
7.4.10.1. Market Size and Forecast, By Form
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By Distribution Channel
7.4.11. Rest of Asia-Pacific Atorvastatin Calcium Market
7.4.11.1. Market Size and Forecast, By Form
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By Distribution Channel
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Form
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By Distribution Channel
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Atorvastatin Calcium Market
7.5.6.1. Market Size and Forecast, By Form
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By Distribution Channel
7.5.7. South Africa Atorvastatin Calcium Market
7.5.7.1. Market Size and Forecast, By Form
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By Distribution Channel
7.5.8. Saudi Arabia Atorvastatin Calcium Market
7.5.8.1. Market Size and Forecast, By Form
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By Distribution Channel
7.5.9. Rest of LAMEA Atorvastatin Calcium Market
7.5.9.1. Market Size and Forecast, By Form
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Mylan Pharmaceuticals Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Novartis AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. GlaxoSmithKline Plc
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Amgen Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Sanofi SA
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Teva Pharmaceuticals Industries Ltd
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Merck And Co. Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Bristol-Myers Squibb Company
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. AstraZeneca Plc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Pfizer Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 2. ASTAXANTHIN MARKET FOR NATURAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ASTAXANTHIN MARKET FOR SYNTHETIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 5. ASTAXANTHIN MARKET FOR DRY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ASTAXANTHIN MARKET FOR LIQUID, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 8. ASTAXANTHIN MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. ASTAXANTHIN MARKET FOR COSMETICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. ASTAXANTHIN MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ASTAXANTHIN MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA ASTAXANTHIN MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. U.S. ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. CANADA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 20. CANADA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE ASTAXANTHIN MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. FRANCE ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 30. FRANCE ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. ITALY ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 36. ITALY ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 37. ITALY ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. SPAIN ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 39. SPAIN ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. UK ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 42. UK ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 43. UK ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. REST OF EUROPE ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. ASIA-PACIFIC ASTAXANTHIN MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. CHINA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 52. CHINA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 53. CHINA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. INDIA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 58. INDIA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 59. INDIA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH KOREA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH KOREA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 64. AUSTRALIA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. REST OF ASIA-PACIFIC ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. LAMEA ASTAXANTHIN MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. BRAZIL ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. SOUTH AFRICA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 77. SOUTH AFRICA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. REST OF LAMEA ASTAXANTHIN MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA ASTAXANTHIN MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA ASTAXANTHIN MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. INNOBIO LIMITED: KEY EXECUTIVES
TABLE 86. INNOBIO LIMITED: COMPANY SNAPSHOT
TABLE 87. INNOBIO LIMITED: OPERATING SEGMENTS
TABLE 88. INNOBIO LIMITED: PRODUCT PORTFOLIO
TABLE 89. INNOBIO LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. DIVIS LABORATORIES LIMITED: KEY EXECUTIVES
TABLE 91. DIVIS LABORATORIES LIMITED: COMPANY SNAPSHOT
TABLE 92. DIVIS LABORATORIES LIMITED: OPERATING SEGMENTS
TABLE 93. DIVIS LABORATORIES LIMITED: PRODUCT PORTFOLIO
TABLE 94. DIVIS LABORATORIES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. ALGAECAN BIOTECH: KEY EXECUTIVES
TABLE 96. ALGAECAN BIOTECH: COMPANY SNAPSHOT
TABLE 97. ALGAECAN BIOTECH: OPERATING SEGMENTS
TABLE 98. ALGAECAN BIOTECH: PRODUCT PORTFOLIO
TABLE 99. ALGAECAN BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. ALGA TECHNOLOGIES: KEY EXECUTIVES
TABLE 101. ALGA TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 102. ALGA TECHNOLOGIES: OPERATING SEGMENTS
TABLE 103. ALGA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 104. ALGA TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. CYANOTECH CORPORATION.: KEY EXECUTIVES
TABLE 106. CYANOTECH CORPORATION.: COMPANY SNAPSHOT
TABLE 107. CYANOTECH CORPORATION.: OPERATING SEGMENTS
TABLE 108. CYANOTECH CORPORATION.: PRODUCT PORTFOLIO
TABLE 109. CYANOTECH CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. OTSUKA PHARMACEUTICAL CO.: KEY EXECUTIVES
TABLE 111. OTSUKA PHARMACEUTICAL CO.: COMPANY SNAPSHOT
TABLE 112. OTSUKA PHARMACEUTICAL CO.: OPERATING SEGMENTS
TABLE 113. OTSUKA PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 114. OTSUKA PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. CARDAX: KEY EXECUTIVES
TABLE 116. CARDAX: COMPANY SNAPSHOT
TABLE 117. CARDAX: OPERATING SEGMENTS
TABLE 118. CARDAX: PRODUCT PORTFOLIO
TABLE 119. CARDAX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. FENCHEM: KEY EXECUTIVES
TABLE 121. FENCHEM: COMPANY SNAPSHOT
TABLE 122. FENCHEM: OPERATING SEGMENTS
TABLE 123. FENCHEM: PRODUCT PORTFOLIO
TABLE 124. FENCHEM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. BGG: KEY EXECUTIVES
TABLE 126. BGG: COMPANY SNAPSHOT
TABLE 127. BGG: OPERATING SEGMENTS
TABLE 128. BGG: PRODUCT PORTFOLIO
TABLE 129. BGG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: KEY EXECUTIVES
TABLE 131. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 132. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: OPERATING SEGMENTS
TABLE 133. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 134. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ASTAXANTHIN MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ASTAXANTHIN MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ASTAXANTHIN MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALASTAXANTHIN MARKET
FIGURE 10. GLOBAL ASTAXANTHIN MARKET SEGMENTATION, BY SOURCE
FIGURE 11. ASTAXANTHIN MARKET FOR NATURAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ASTAXANTHIN MARKET FOR SYNTHETIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ASTAXANTHIN MARKET SEGMENTATION, BY FORM
FIGURE 14. ASTAXANTHIN MARKET FOR DRY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ASTAXANTHIN MARKET FOR LIQUID, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL ASTAXANTHIN MARKET SEGMENTATION, BY APPLICATION
FIGURE 17. ASTAXANTHIN MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. ASTAXANTHIN MARKET FOR COSMETICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. ASTAXANTHIN MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 24. COMPETITIVE DASHBOARD
FIGURE 25. COMPETITIVE HEATMAP: ASTAXANTHIN MARKET
FIGURE 26. TOP PLAYER POSITIONING, 2023
FIGURE 27. INNOBIO LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. INNOBIO LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. INNOBIO LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. DIVIS LABORATORIES LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. DIVIS LABORATORIES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. DIVIS LABORATORIES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. ALGAECAN BIOTECH: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. ALGAECAN BIOTECH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. ALGAECAN BIOTECH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ALGA TECHNOLOGIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ALGA TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ALGA TECHNOLOGIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. CYANOTECH CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. CYANOTECH CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. CYANOTECH CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. OTSUKA PHARMACEUTICAL CO.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. CARDAX: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. CARDAX: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. CARDAX: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. FENCHEM: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. FENCHEM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. FENCHEM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. BGG: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. BGG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. BGG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security